-
公开(公告)号:US20240319090A1
公开(公告)日:2024-09-26
申请号:US18733911
申请日:2024-06-05
IPC分类号: G01N21/39 , C12M1/34 , G01N21/3577 , G01N21/359 , G01N21/45 , G01N33/68
CPC分类号: G01N21/39 , C12M41/32 , G01N21/3577 , G01N21/359 , G01N21/45 , G01N33/6854 , G01N2201/06113
摘要: A method for studying cell viability and protein aggregation involves establishing a Fabry Perot etalon signal within an optical spectroscopic feature, e.g., in the near infrared region. Protein aggregation and cell viability can be reflected by changes observed in the magnitude of the Fourier Transform peaks observed in the frequency or space domain associated with the contrast of the etalon. In short, the presence of viable cells and protein aggregates can degrade the etalon contrast of an etalon window. In some cases, the concentration of cells and monomeric protein can be measured as well.
-
公开(公告)号:US20240218313A1
公开(公告)日:2024-07-04
申请号:US18609573
申请日:2024-03-19
发明人: Matthew ANGELINI , Ashley WITMER , Anthony DEBIASE
CPC分类号: C12M41/46 , C12M21/14 , C12M29/04 , C12M29/10 , C12M41/14 , C12M41/26 , C12M41/30 , C12M41/32 , C12M41/38 , C12M43/00
摘要: A method of controlling a bioreactor system includes providing a cell culture in a bioreactor, wherein conditions in the bioreactor enable the cell culture to produce a protein of interest (POI), measuring process parameters (PPs) of the culture within the bioreactor by RAMAN, wherein the process parameters are selected from the group consisting of nutrient concentration, viable cell concentration, and protein attributes, measuring a predetermined weight of the bioreactor with the cell culture, removing cell-free spent media from the cell culture using a first output conduit at a first specified rate, removing cells from the cell culture using a second output conduit at a second specified rate, and introducing one or both of fresh media or nutrients into the cell culture using an input conduit at a third specified rate.
-
公开(公告)号:US12024479B2
公开(公告)日:2024-07-02
申请号:US18340077
申请日:2023-06-23
发明人: Bruce Kreischer , Kendall M. Hurst , Eric D. Schwerdtfeger , Steven M. Bischof , Jared Fern , Kent E. Mitchell , James Hillier
CPC分类号: C07C2/32 , B01J8/10 , B01J8/1809 , B01J8/1854 , C12M41/30 , C12M41/32 , B01J8/001 , B01J19/0006 , B01J19/0013 , B01J2208/00548 , B01J2208/00663 , B01J8/001 , B01J19/0006 , B01J19/0013
摘要: Methods for determining ethylene concentration in an ethylene oligomerization reactor using an ultrasonic flow meter are described, and these methods are integrated into ethylene oligomerization processes and related oligomerization reactor systems.
-
公开(公告)号:US20240209306A1
公开(公告)日:2024-06-27
申请号:US18287287
申请日:2022-12-21
发明人: Shannon HALL , Ouwei WANG , Brian LEE , Charles EMRICH
CPC分类号: C12M41/48 , C12M27/20 , C12M29/06 , C12M41/12 , C12M41/26 , C12M41/32 , C12M41/34 , C12N1/20
摘要: Methods and systems for iteratively improving culture condition for at least one culture output in a culture process. The methods comprise: a) providing a continuous culture of cells in a bioreactor, wherein the cells are cultured under culture conditions that comprise a set of culture parameters. and wherein the culture of cells produces at least one culture output at a first measure: b) while maintaining the cells in continuous culture, iteratively testing different culture conditions by: (i) selecting a new culture condition comprising a new set of culture parameters predicted to improve the measure of the culture output: (ii) perturbing the cells with the new culture conditions: and (iii) determining a new measure of the culture output: wherein testing is iterated to produce a plurality of improvements in the measure of culture output. The iterative process can be performed by an automated artificial intelligence.
-
公开(公告)号:US12018242B2
公开(公告)日:2024-06-25
申请号:US16956888
申请日:2018-12-21
CPC分类号: C12M45/02 , C12M25/16 , C12M27/02 , C12M29/06 , C12M33/00 , C12M41/00 , C12M41/26 , C12M41/32 , C12N5/04
摘要: The present invention relates to bioreactors for root organ cultures that enable large parts of the inoculation or biomass transfer, cultivation and harvest of the cultures to be performed outside of an aseptic environment. The present invention further relates to methods of producing and aseptically harvesting roots, and methods of producing root cultures using the aforementioned bioreactors alone or as part of an apparatus further comprising an inoculation vessel or at least one further bioreactor.
-
公开(公告)号:US20240182844A1
公开(公告)日:2024-06-06
申请号:US18545965
申请日:2023-12-19
申请人: Oribiotech Ltd.
发明人: Christopher Mason , Farlan Veraitch
摘要: The present invention provides a method for culturing cells in a cell culture container having a base section, a top section arranged in parallel with the top section and a wall element arranged between the top section and the base section and defining an internal lumen of the container, in which the wall element of the container is compressible with respect to the top and bottom section, and in which the top section of the container has an optionally sealable inlet, in which the container is composed of a flexible material, comprising culturing cells in a culture medium in the cell culture container. Also provided is a cell culture container having a base section, a top section arranged in parallel with the top section and a wall element arranged between the top section and the base section and defining an internal lumen of the container, in which the wall element of the container is compressible with respect to the top and bottom section, and in which the top section of the container has an optionally sealable inlet, in which the wall element of the container is composed of a flexible material.
-
7.
公开(公告)号:US20240142461A1
公开(公告)日:2024-05-02
申请号:US18379467
申请日:2023-10-12
发明人: Sonia Bedi , Pinaki Ranadive
CPC分类号: G01N33/6803 , C12M23/06 , C12M41/32 , C12M41/44
摘要: The present invention generally pertains to methods of predicting water loss from a sample. In particular, the present invention pertains to modeling water loss from a drug substance in silicone tubing based on the properties of the tubing and the drug substance.
-
公开(公告)号:US11952567B2
公开(公告)日:2024-04-09
申请号:US18201025
申请日:2023-05-23
IPC分类号: B01D63/02 , B01D61/14 , B01D61/22 , B01D63/04 , B01D65/02 , C12M1/00 , C12M1/26 , C12M1/34 , C12M1/36 , C12N1/02 , C12N1/12
CPC分类号: C12N1/12 , B01D61/146 , B01D61/22 , B01D63/02 , B01D63/04 , B01D63/046 , B01D65/02 , C12M21/02 , C12M29/04 , C12M29/16 , C12M29/18 , C12M29/20 , C12M33/14 , C12M41/32 , C12M41/44 , C12M41/48 , C12M45/00 , C12M47/02 , C12N1/02 , B01D2311/04 , B01D2311/06 , B01D2311/2626 , B01D2311/2688 , B01D2313/18 , B01D2313/26 , B01D2313/50 , B01D2315/06 , B01D2315/08 , B01D2317/02 , B01D2317/022 , B01D2321/04 , B01D2321/18 , B01D2321/185 , B01D2321/40
摘要: Algae harvesting and cultivating systems and methods for producing high concentrations of algae product with minimal energy. In an embodiment, a dead-end filtration system and method includes at least one tank and a plurality hollow fiber membranes positioned in the at least one tank. An algae medium is pulled through the hollow fiber membranes such that a retentate and a permeate are produced.
-
公开(公告)号:US20240110135A1
公开(公告)日:2024-04-04
申请号:US18084588
申请日:2022-12-20
发明人: Yulin CAO
CPC分类号: C12M21/08 , A01N1/0247 , C12M23/44 , C12M29/10 , C12M41/32 , C12M41/48 , G01N33/5088
摘要: A micro-organ specificity maintenance system includes a micro-organ specificity parallel reactor module for storing and culturing vascularized micro-organs; a feeding module for feeding culture solutions to the micro-organ specificity parallel reactor module; an injection module for injecting medical solutions containing traditional Chinese medicine micromolecules into the micro-organ specificity parallel reactor module; a micro-organ circulation coupling module for transmitting venous flow and arterial flow to the micro-organ specificity parallel reactor module; and a micro-organ neural coupling module for transmitting neural network signals to the micro-organ specificity parallel reactor module. The micro-organ specificity maintenance system provided in the disclosure has the advantage that an extracorporeal circulation system and internal vascular systems of complex organs are organically integrated and connected.
-
-
-
-
-
-
-
-